Search Results - "Yan, Huaqing"

Refine Results
  1. 1

    Genetically identification of endometriosis and cancers risk in women through a two-sample Mendelian randomization study by Zhang, Liqi, Yan, Huaqing

    Published in Scientific reports (10-04-2024)
    “…Endometriosis is a prevalent and chronic inflammatory gynecologic disorder affecting approximately 6–10% of women globally, and has been associated with an…”
    Get full text
    Journal Article
  2. 2

    Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis by Xiang, Jianjian, Yan, Huaqing, Li, Jiangfeng, Wang, Xiao, Chen, Hong, Zheng, Xiangyi

    Published in World journal of surgical oncology (13-02-2019)
    “…Because conventional prostate biopsy has some limitations, optimal variations of prostate biopsy strategies have emerged to improve the diagnosis rate of…”
    Get full text
    Journal Article
  3. 3

    YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer by Li, Jiangfeng, Xie, Haiyun, Ying, Yufan, Chen, Hong, Yan, Huaqing, He, Liujia, Xu, Mingjie, Xu, Xin, Liang, Zhen, Liu, Ben, Wang, Xiao, Zheng, Xiangyi, Xie, Liping

    Published in Molecular cancer (29-10-2020)
    “…Background N6-methyladenosine (m.sup.6A) is the most abundant modification in mRNA of humans. Emerging evidence has supported the fact that m.sup.6A is…”
    Get full text
    Journal Article
  4. 4

    Identification of m6A suppressor EIF4A3 as a novel cancer prognostic and immunotherapy biomarker through bladder cancer clinical data validation and pan-cancer analysis by Yan, Huaqing, Zhang, Liqi, Li, Rubing

    Published in Scientific reports (30-09-2023)
    “…EIF4A3 represents a novel m6A suppressor that exerts control over the global m6A mRNA modification level, therefore influencing gene destiny. Despite…”
    Get full text
    Journal Article
  5. 5

    Roles and mechanisms of the m6A reader YTHDC1 in biological processes and diseases by Yan, Huaqing, Zhang, Liqi, Cui, Xiaobo, Zheng, Sinian, Li, Rubing

    Published in Cell death discovery (02-05-2022)
    “…N6-methyladenosine (m 6 A) is a key area in Epigenetics and has been increasingly focused these years. In the m 6 A process, readers recognize the m 6 A…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Fruit and Vegetable Consumption and the Risk of Prostate Cancer: A Systematic Review and Meta-Analysis by Yan, Huaqing, Cui, Xiaobo, Zhang, Peng, Li, Rubing

    Published in Nutrition and cancer (2022)
    “…Emerging researches has evaluated whether fruit and vegetable consumption reduce the risk of prostate cancer. However, the conclusions of published articles…”
    Get full text
    Journal Article
  8. 8

    The dual role of N6‐methyladenosine modification of RNAs is involved in human cancers by He, Liujia, Li, Jiangfeng, Wang, Xiao, Ying, Yufan, Xie, Haiyun, Yan, Huaqing, Zheng, Xiangyi, Xie, Liping

    Published in Journal of cellular and molecular medicine (01-10-2018)
    “…As the most abundant and reversible RNA modification in eukaryotic cells, m6A triggers a new layer of epi‐transcription. M6A modification occurs through a…”
    Get full text
    Journal Article
  9. 9

    METTL3/YTHDF2 m6A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer by Xie, Haiyun, Li, Jiangfeng, Ying, Yufan, Yan, Huaqing, Jin, Ke, Ma, Xueyou, He, Liujia, Xu, Xin, Liu, Ben, Wang, Xiao, Zheng, Xiangyi, Xie, Liping

    Published in Journal of cellular and molecular medicine (01-04-2020)
    “…N6‐Methyladenosine (m6A) modification, the most prevalent modification of eukaryotic messenger RNA (mRNA), is involved in the progression of various tumours…”
    Get full text
    Journal Article
  10. 10

    The prognostic and immunological role of MYB: from bladder cancer validation to pan-cancer analysis by Cui, Xiaobo, Zhang, Chao, Zhang, Liqi, Yan, Huaqing

    Published in Bioscience reports (01-04-2023)
    “…MYB proto-oncogene is verified as a transcription factor. Although emerging evidence showed that MYB plays a critical part in tumor progression and immunity, a…”
    Get full text
    Journal Article
  11. 11

    Dual regulatory role of CCNA2 in modulating CDK6 and MET‐mediated cell‐cycle pathway and EMT progression is blocked by miR‐381‐3p in bladder cancer by Li, Jiangfeng, Ying, Yufan, Xie, Haiyun, Jin, Ke, Yan, Huaqing, Wang, Song, Xu, Mingjie, Xu, Xin, Wang, Xiao, Yang, Kai, Zheng, Xiangyi, Xie, Liping

    Published in The FASEB journal (01-01-2019)
    “…ABSTRACT Emerging evidence has elucidated that microRNAs (miRNAs) transcribed from miRNA cluster at DLK‐DIO3 imprinted domain are involved in various cancers…”
    Get full text
    Journal Article
  12. 12

    MIR-300 in the imprinted DLK1-DIO3 domain suppresses the migration of bladder cancer by regulating the SP1/MMP9 pathway by Yan, Huaqing, Li, Jiangfeng, Ying, Yufan, Xie, Haiyun, Chen, Hong, Xu, Xin, Zheng, Xiangyi

    Published in Cell cycle (Georgetown, Tex.) (17-12-2018)
    “…Emerging research has suggested that miRNAs play a significant role in oncogenesis and tumor progression by regulating multiple molecular pathways. Here, we…”
    Get full text
    Journal Article
  13. 13

    From Cognitive MR-Targeted Fusion Prostate Biopsy to Radical Prostatectomy: Incidence and Predictors of Gleason Grade Group Upgrading in a Chinese Cohort by Yan, Huaqing, Wu, Yiming, Cui, Xiaobo, Zheng, Sinian, Zhang, Peng, Li, Rubing

    Published in BioMed research international (17-08-2022)
    “…Purpose. To access the incidence and predictors of Gleason grade group upgrading from cognitive MR-targeted fusion prostate biopsy to radical prostatectomy in…”
    Get full text
    Journal Article
  14. 14

    CCND1, NOP14 and DNMT3B are involved in miR‐502‐5p–mediated inhibition of cell migration and proliferation in bladder cancer by Ying, Yufan, Li, Jiangfeng, Xie, Haiyun, Yan, Huaqing, Jin, Ke, He, Liujia, Ma, Xueyou, Wu, Jian, Xu, Xin, Fang, Jiajie, Wang, Xiao, Zheng, Xiangyi, Liu, Ben, Xie, Liping

    Published in Cell proliferation (01-02-2020)
    “…Objectives Downregulation of miR‐502‐5p has emerged as a critical factor in tumour progression in several cancers. Herein, we elucidated the role of miR‐502‐5p…”
    Get full text
    Journal Article
  15. 15

    The influence of prostate volume on pathological outcomes after radical prostatectomy: A single-center retrospective study by Li, Qinchen, Yang, Zitong, Wang, Zhize, Sun, Jiazhu, Wen, Chao, Yan, Huaqing, Shen, Haixiang, Wang, Weiyu, Xu, Bohan, Xiang, Jianjian, Teng, Xiaodong, Zhang, Cheng, Zheng, Xiangyi, Xie, Liping

    Published in Medicine (Baltimore) (08-12-2023)
    “…Currently, the association between prostate volume (PV) or prostate weight with pathological outcomes in patients with prostate cancer (PCa) is not well…”
    Get full text
    Journal Article
  16. 16

    LncRNA FGF14‐AS2 represses growth of prostate carcinoma cells via modulating miR‐96‐5p/AJAP1 axis by Li, Rubing, Chen, Yingcong, Wu, Jingwei, Cui, Xiaobo, Zheng, Sinian, Yan, Huaqing, Wu, Yiming, Wang, Feng

    Published in Journal of clinical laboratory analysis (01-11-2021)
    “…Objective This investigation devoted to lncRNA FGF14 antisense RNA 2 (FGF14‐AS2) in prostate carcinoma progression. Methods The levels of lncRNA FGF14‐AS2,…”
    Get full text
    Journal Article
  17. 17

    Roles and mechanisms of the m 6 A reader YTHDC1 in biological processes and diseases by Yan, Huaqing, Zhang, Liqi, Cui, Xiaobo, Zheng, Sinian, Li, Rubing

    Published in Cell death discovery (02-05-2022)
    “…N6-methyladenosine (m A) is a key area in Epigenetics and has been increasingly focused these years. In the m A process, readers recognize the m A modification…”
    Get full text
    Journal Article
  18. 18

    METTL3/YTHDF2 m 6 A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer by Xie, Haiyun, Li, Jiangfeng, Ying, Yufan, Yan, Huaqing, Jin, Ke, Ma, Xueyou, He, Liujia, Xu, Xin, Liu, Ben, Wang, Xiao, Zheng, Xiangyi, Xie, Liping

    Published in Journal of cellular and molecular medicine (01-04-2020)
    “…N6-Methyladenosine (m A) modification, the most prevalent modification of eukaryotic messenger RNA (mRNA), is involved in the progression of various tumours…”
    Get full text
    Journal Article
  19. 19

    CRISPR-ON-Mediated KLF4 overexpression inhibits the proliferation, migration and invasion of urothelial bladder cancer in vitro and in vivo by Xu, Xin, Li, Jiangfeng, Zhu, Yi, Xie, Bo, Wang, Xiao, Wang, Song, Xie, Haiyun, Yan, Huaqing, Ying, Yufan, Lin, Yiwei, Liu, Ben, Wang, Wei, Zheng, Xiangyi

    Published in Oncotarget (24-11-2017)
    “…Kruppel like factor 4 (KLF4), a transcription factor associated with carcinogenesis and tumor progression, plays an important role in various malignancies. In…”
    Get full text
    Journal Article
  20. 20

    Pioglitazone use in patients with diabetes and risk of bladder cancer: a systematic review and meta-analysis by Yan, Huaqing, Xie, Haiyun, Ying, Yufan, Li, Jiangfeng, Wang, Xiao, Xu, Xin, Zheng, Xiangyi

    Published in Cancer management and research (01-01-2018)
    “…Pioglitazone has been reported to increase the risk of bladder cancer but the conclusions of published clinical studies are confusing. We conducted a…”
    Get full text
    Journal Article